Discretionary

The policy response to coronavirus has given risk committees a new challenge to face – the threat of inflation.

Firms may not see instant profit from a Covid-19 cure, but it could win the industry the public approval it needs.

Alternative data isn’t a crystal ball – but in the depths of the coronacrisis, it was the next best thing.

Portfolio Manager Jose Wynne explains why some emerging markets are better suited for quantitative easing than others.

Is quantitative easing suited to emerging markets? Can it actually do more harm than good? Can the perfect dose of QE be calibrated?

We have a positive outlook on convertible bonds for three reasons: downside risk mitigation, a cheap entry point and improving liquidity.

Is investors’ faith in monetary policies and a V-shaped recovery misplaced? Guillermo Ossés, Head of Emerging-Market Debt, discusses why risks in emerging markets may be higher than expected.

A debt overhang, misplaced faith in central banks and no global V-shaped recovery are likely to leave emerging-market sovereign assets exposed to substantial downside risks, either through inflation or default.

The People’s Bank of China could supplement its use of credit channels with the ‘whatever works’ approach of western institutions. This article was originally published in the Financial Times.

After the fastest bear market ever, we’ve had one of the fastest rebounds. So, is the rally done for now?

Establishing a cost on pollution is critical if we are to tackle climate change. Carbon pricing is the attempt to do just that.